IAS Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth quarter revenue increased 14% to $134.3 million

Fourth quarter net income of $10.2 million at an 8% margin; fourth quarter adjusted EBITDA increased 19% to $47.5 million at a 35% margin

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Integral Ad Science Holding Corp. (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the fourth quarter and full year ended December 31, 2023.

"We ended 2023 with strong fourth quarter performance across optimization and measurement with revenue growth of 16% and 18%, respectively," said Lisa Utzschneider, CEO of IAS. "Social media revenue increased 37% in the fourth quarter as marketers trusted IAS to maximize their advertising spend globally, particularly in short-form video. In 2024, we will continue to invest in data science and innovate with AI to empower marketers with actionable data to drive superior results. We expect to deliver double-digit revenue growth for the full year."

Fourth Quarter 2023 Financial Highlights

    --  Total revenue was $134.3 million, a 14% increase compared to $117.4
        million in the prior-year period.
    --  Optimization revenue was $63.6 million, a 16% increase compared to $55.1
        million in the prior-year period.
    --  Measurement revenue was $52.6 million, an 18% increase compared to $44.7
        million in the prior-year period.
    --  Publisher revenue was $18.1 million, a 2% increase compared to $17.6
        million in the prior-year period.
    --  International revenue, excluding the Americas, was $43.3 million, a 16%
        increase compared to $37.3 million in the prior-year period, or 32% of
        total revenue for the fourth quarter of 2023.
    --  Gross profit was $106.0 million, an 11% increase compared to $95.5
        million in the prior-year period. Gross profit margin was 79% for the
        fourth quarter of 2023.
    --  Net income was $10.2 million, or $0.06 per basic and diluted share,
        compared to $11.5 million, or $0.07 per basic and diluted share, in the
        prior-year-period. Net income margin was 8% for the fourth quarter of
        2023.
    --  Adjusted EBITDA* was $47.5 million, a 19% increase compared to $40.0
        million in the prior-year period. Adjusted EBITDA* margin was 35% for
        the fourth quarter of 2023.

Full Year 2023 Financial Highlights

    --  Total revenue was $474.4 million, a 16% increase compared to $408.3
        million in the prior year.
    --  Optimization revenue was $224.5 million, an 18% increase compared to
        $190.6 million in the prior year.
    --  Measurement revenue was $186.0 million, a 20% increase compared to
        $154.9 million in the prior year.
    --  Publisher revenue was $63.8 million, a 2% increase compared to $62.8
        million in the prior year.
    --  International revenue, excluding the Americas, was $146.8 million, a 14%
        increase compared to $129.1 million in the prior year, or 31% of total
        revenue for the full year 2023.
    --  Gross profit was $375.0 million, a 13% increase compared to $332.6
        million in the prior year. Gross profit margin was 79% for the full year
        2023.
    --  Net income was $7.2 million, or $0.04 per diluted share, compared to
        $15.4 million, or $0.10 per basic and diluted share, in the prior year.
        Net income margin was 2% for the full year 2023.
    --  Adjusted EBITDA* was $159.5 million, a 26% increase compared to $126.6
        million in the prior year. Adjusted EBITDA* margin was 34% for the full
        year 2023.
    --  Cash and cash equivalents were $124.8 million at December 31, 2023.

Recent Business Highlights

    --  Meta Expansion - In February, IAS announced the availability of its
        AI-driven Total Media Quality (TMQ) brand safety and suitability
        measurement product across Facebook and Instagram Feed and Reels. IAS's
        new post-bid brand safety and suitability expansion with Meta gives
        advertisers increased transparency into whether their campaigns are
        appearing next to safe and suitable content.
    --  IAS MRC Continuing Accreditation for Measurement of Meta Platforms - In
        January, IAS received continuing accreditation from the MRC for
        viewability measurement of Meta, including impressions and two-second
        video viewability, on Facebook Feed and Instagram Feed and Stories.
    --  YouTube TMQ Expansion - During the fourth quarter, IAS expanded its
        partnership to YouTube Shorts to offer its brand safety and suitability
        measurement product to advertisers for YouTube Shorts inventory, as part
        of its existing Total Media Quality for YouTube product suite.
    --  X Expansion - In February, IAS expanded its partnership with X to all
        U.S. advertisers. IAS classifies all vertical video ad adjacencies for
        brand safety and suitability aligned to the GARM framework, giving
        advertisers maximum control over where their ads appear on the X
        vertical video feed.
    --  Quality Attention Expansion - In January, IAS announced the general
        availability of its Quality Attention measurement product. Quality
        Attention uses advanced machine learning technology, actionable data
        from Lumen Research's eye-tracking technology, and a variety of signals
        obtained as part of IAS's core technology.

Financial Outlook

"We reported profitable growth in the fourth quarter with a 14% revenue increase at a 35% adjusted EBITDA* margin," said Tania Secor, CFO of IAS. "As we move through 2024, we expect to ramp both revenue growth and profitability from forecasted first quarter levels as we expand availability and customer adoption of new products. We also plan to maintain our strong financial profile and healthy balance sheet."

IAS is introducing the following financial outlook for the first quarter and full year 2024:

First Quarter Ending March 31, 2024:

    --  Total revenue of $111 million to $113 million
    --  Adjusted EBITDA* of $28 million to $30 million

Year Ending December 31, 2024:

    --  Total revenue of $530 million to $540 million
    --  Adjusted EBITDA* of $171 million to $179 million

* See "Supplemental Disclosure Regarding Non-GAAP Financial Information" section herein for an explanation of Non-GAAP measures. IAS is unable to provide a reconciliation for forward-looking guidance of Adjusted EBITDA to net income (loss), the most closely comparable GAAP measure, because certain material reconciling items, such as depreciation and amortization, interest expense, income tax expense (benefit), restructuring and severance costs, and acquisition and integration costs, cannot be estimated due to factors outside of IAS's control and could have a material impact on the reported results. However, IAS estimates stock-based compensation expense for the first quarter of 2024 in the range of $14 million to $16 million and for the full year 2024 in the range of $72 million to $76 million. A reconciliation is not available without unreasonable effort.


                                                                                      
            
        INTEGRAL AD SCIENCE HOLDING CORP.

                                                                                         
            
        CONSOLIDATED BALANCE SHEETS







         
              (IN THOUSANDS, EXCEPT SHARE DATA)                                                                                December 31, 2023 December 31, 2022



         
              ASSETS



         Current assets:



         Cash and cash equivalents                                                                                                            $124,759            $86,877



         Restricted cash                                                                                                                            54                 45



         Accounts receivable, net                                                                                                               74,609             67,884



         Unbilled receivables                                                                                                                   46,548             41,550



         Prepaid expenses and other current assets                                                                                              18,959             24,761



         Due from related party                                                                                                                      -                29



         Total current assets                                                                                                                  264,929            221,146



         Property and equipment, net                                                                                                             3,769              2,412



         Internal use software, net                                                                                                             40,301             23,642



         Intangible assets, net                                                                                                                178,908            217,558



         Goodwill                                                                                                                              675,282            674,094



         Operating lease right-of-use assets, net                                                                                               21,668             22,787



         Deferred tax asset, net                                                                                                                 2,465              2,020



         Other long-term assets                                                                                                                  4,402              5,024



         Total assets                                                                                                                       $1,191,724         $1,168,683



         
              LIABILITIES AND STOCKHOLDERS' EQUITY



         Current liabilities:



         Accounts payable and accrued expenses                                                                                                 $72,232            $60,799



         Operating lease liabilities, current                                                                                                    9,435              6,749



         Due to related party                                                                                                                      121                122



         Deferred revenue                                                                                                                          682                 99



         Total current liabilities                                                                                                              82,470             67,769



         Deferred tax liability, net                                                                                                            20,367             45,495



         Long-term debt                                                                                                                        153,725            223,262



         Operating lease liabilities, non-current                                                                                               19,523             22,875



         Other long-term liabilities                                                                                                             6,183              1,066



         Total liabilities                                                                                                                     282,268            360,467



         Commitments and Contingencies



         Stockholders' Equity



         Preferred Stock, $0.001 par value, 50,000,000 shares authorized at December 31, 2023; 0                                                     -
      shares issued and outstanding at December 31, 2023 and 2022



         Common Stock, $0.001 par value, 500,000,000 shares authorized at December 31, 2023,                                                       159                154
      158,757,620 and 153,990,128 shares issued and outstanding at December 31, 2023 and
      2022, respectively



         Additional paid-in-capital                                                                                                            901,259            810,186



         Accumulated other comprehensive loss                                                                                                    (916)           (2,899)



         Accumulated earnings                                                                                                                    8,954                775



         Total stockholders' equity                                                                                                            909,456            808,216



         Total liabilities and stockholders' equity                                                                                         $1,191,724         $1,168,683


                                                                        
        
                INTEGRAL AD SCIENCE HOLDING CORP.

                                                          
              
          CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

                                                                             
              
                (UNAUDITED)




                                                                                                                                                       Three months ended                      Year ended

                                                                                                                                                                           December 31,                   December 31,



     
                (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)                                                                                2023          2022             2023          2022



     Revenue                                                                                                                                 $134,295      $117,435         $474,369      $408,348



     Operating expenses:



     Cost of revenue (excluding depreciation and amortization shown below)                                                                     28,252        21,891           99,352        75,755



     Sales and marketing                                                                                                                       30,423        28,325          117,989       106,286



     Technology and development                                                                                                                19,056        22,280           72,906        76,351



     General and administrative                                                                                                                25,961        23,572          111,634        79,654



     Depreciation and amortization                                                                                                             14,593        12,811           54,966        50,396



     Foreign exchange (gain) loss, net                                                                                                          (501)        1,246              430         4,749



     Total operating expenses                                                                                                                 117,784       110,125          457,277       393,191



     Operating income                                                                                                                          16,511         7,310           17,092        15,157



     Interest expense, net                                                                                                                    (2,489)      (3,194)        (12,236)      (9,053)



     Employee retention tax credit                                                                                                                                                        6,981



     Net income before income taxes                                                                                                            14,022         4,116            4,856        13,085



     (Provision) benefit from income taxes                                                                                                    (3,858)        7,371            2,382         2,288



     Net income                                                                                                                               $10,164       $11,487           $7,238       $15,373



     Net income per share:



     Basic                                                                                                                                      $0.06         $0.07            $0.05         $0.10



     Diluted                                                                                                                                    $0.06         $0.07            $0.04         $0.10



     Weighted average shares outstanding:



     Basic                                                                                                                                158,243,619   153,792,438      156,272,335   154,699,694



     Diluted                                                                                                                              163,060,805   155,288,725      161,723,131   157,258,083



     Other comprehensive income:



     Foreign currency translation adjustments                                                                                                   2,772         8,634            1,983       (2,584)



     Total comprehensive income                                                                                                               $12,936       $20,121           $9,221       $12,789


                                                                                                        
          
                INTEGRAL AD SCIENCE HOLDING CORP.

                                                                                       
              
            CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'/MEMBERS' EQUITY




                                                                                      Members' Interest                                                       Common Stock


                   
              
                (IN THOUSANDS, EXCEPT UNITS         Units                       Amount                                 Shares                       Amount         Additional      Accumulated               Accumulated                 Total members'/
                                                   AND SHARES DATA)                                                                                                                                                           earnings                 stockholders'
                                                                                                                                                                                              paid-in          other                                       equity
                                                                                                                                                                                                                                       (deficit)
                                                                                                                                                                                              capital      comprehensive

                                                                                                                                                                                                           income (loss)



              
                Balances at January 1, 2021                  134,039,494                        $553,717                                             
              $           - 
     $            -            $4,523                $(126,761)                        $431,479



              Repurchase of units                                          (99,946)                          (413)                                                                                                                           (791)                         (1,204)



              Units vested                                                   17,486



              Option exercises                                              246,369                           1,075                                                                                 3,360                                                                       4,435



              Foreign currency translation                                        -                                                                                                                               (4,838)                                                  (4,838)
    adjustment



              Net loss prior to corporate conversion                              -                                                                                                                                                       (37,832)                        (37,832)



              Conversion to Delaware corporation                      (134,203,403)                      (554,379)                          134,203,403                             134           388,860                                     165,385



              Rounding units/shares as a result of                                -                                                                (17)
    corporate conversion



              Stock-based compensation                                            -                                                                                                              55,222                                                                      55,222



              RSUs vested                                                         -                                                              26,931                                              150                                                                         150



              Issuance of common stock in                                         -                                                          16,821,330                              17           274,340                                                                     274,357
    connection with initial public offering



              Issuance of common stock for Publica                                -                                                           2,888,889                               3            49,628                                                                      49,631
    acquisition



              Issuance of common stock for Context                                -                                                             457,959                                           10,391                                                                      10,391
    acquisition



              Net loss                                                            -                                                                                                                                                       (14,600)                        (14,600)



              
                Balances at December 31, 2021                          - 
              $                 -                          154,398,495                            $154          $781,951             $(315)                $(14,600)                        $767,190



              RSUs vested                                                         -                                                           1,084,966                               1                                                                                            1



              Option exercises                                                    -                                                           1,586,728                               2             7,153                                                                       7,155



              Stock-based compensation                                            -                                                                                                              44,733                                                                      44,733



              Foreign currency translation                                        -                                                                                                                               (2,584)                                                  (2,584)
    adjustment



              Repurchase of common stock                                          -                                                         (3,080,061)                            (3)         (23,652)                                                                   (23,655)



              Net income                                                          -                                                                                                                                                         15,373                           15,373



              
                Balances at December 31, 2022                          - 
              $                 -                          153,990,128                            $154          $810,186           $(2,899)                     $775                         $808,216



              RSUs and MSUs vested                                                -                                                           3,492,130                               4                                                                                            4



              Option exercises                                                    -                                                           1,001,793                               1             7,988                                                                       7,989



              ESPP purchase                                                       -                                                             273,569                                            2,306                                                                       2,306



              Stock-based compensation                                            -                                                                                                              80,779                                                                      80,779



              Foreign currency translation adjustment                             -                                                                                                                                 1,983                                                     1,983



              Adoption of ASC 326, net of tax                                     -                                                                                                                                                            941                              941



              Net income                                                          -                                                                                                                                                          7,238                            7,238



              
                Balances at December 31, 2023                          - 
              $                 -                          158,757,620                            $159          $901,259             $(916)                   $8,954                         $909,456



     
                
                  INTEGRAL AD SCIENCE HOLDING CORP.


     
                
                  CONSOLIDATED STATEMENTS OF CASH FLOWS




                                                                                                   Year ended December 31,



     
                (IN THOUSANDS)                                                            2023      2022



     
                Cash flows from operating activities:



     Net income                                                                           $7,238   $15,373



     Adjustments to reconcile net income to net cash provided by operating activities:



     Depreciation and amortization                                                        54,966    50,396



     Stock-based compensation                                                             81,103    44,752



     Foreign exchange (gain) loss, net                                                     (484)    5,233



     Deferred tax benefit                                                               (21,531)  (8,880)



     Amortization of debt issuance costs                                                     463       464



     Allowance for credit losses                                                           3,816     1,837



     Employee retention tax credit                                                             -  (6,981)



     Impairment of assets                                                                     33       974



     Changes in operating assets and liabilities:



     Increase in accounts receivable                                                     (8,148) (18,581)



     Increase in unbilled receivables                                                    (4,685)  (5,830)



     Decrease (increase) in prepaid expenses and other current assets                      6,418  (10,641)



     Increase in operating leases, net                                                      (29)    (852)



     Decrease (increase) in other long-term assets                                           375   (1,057)



     Increase in accounts payable and accrued expenses and other long-term liabilities    11,478     6,286



     Increase (decrease) in deferred revenue                                                 582      (88)



     Increase in due to/from related party                                                    28        62



     Net cash provided by operating activities                                           131,623    72,467



     
                Cash flows from investing activities:



     Payment for acquisitions, net of acquired cash                                        (966)  (1,603)



     Purchase of property and equipment                                                  (1,975)  (2,016)



     Acquisition and development of internal use software and other                     (31,777) (14,673)



     Net cash used in investing activities                                              (34,718) (18,292)



     
                Cash flows from financing activities:



     Repayment of long-term debt                                                       (145,000) (35,000)



     Repayment of short-term debt                                                              -  (1,816)



     Proceeds from the Revolver                                                           75,000    15,000



     Proceeds from exercise of stock options                                               7,989     7,155



     Payments for repurchase of common stock                                                   - (23,655)



     Cash received from Employee Stock Purchase Program (ESPP)                             3,160       845



     Net cash used in financing activities                                              (58,851) (37,471)



     Net increase in cash, cash equivalents, and restricted cash                          38,054    16,704



     Effect of exchange rate changes on cash and cash equivalents, and restricted cash     (435)  (3,111)



     Cash, cash equivalents, and restricted cash, at beginning of year                    89,671    76,078



     
                Cash, cash equivalents, and restricted cash, at end of year           $127,290   $89,671



     
                Supplemental Disclosures:



     Cash paid during the year for:



     Interest                                                                            $11,229    $8,511



     Taxes                                                                               $10,985   $16,396



     
                Non-cash investing and financing activities:



     Property and equipment acquired included in accounts payable                           $431       $97



     Internal use software acquired included in accounts payable                          $1,444    $1,517



     Lease liabilities arising from right of use assets                                   $6,282   $29,624

Supplemental Disclosure Regarding Non-GAAP Financial Information

We use supplemental measures of our performance, which are derived from our consolidated financial information, but which are not presented in our consolidated financial statements prepared in accordance with GAAP. Adjusted EBITDA is the primary financial performance measure used by management to evaluate our business and monitor ongoing results of operations. Adjusted EBITDA is defined as income/loss before depreciation and amortization, stock-based compensation, interest expense, income taxes, restructuring and severance costs, acquisition and integration costs, foreign exchange gains and losses, and other one-time, non-recurring costs. Adjusted EBITDA margin represents the adjusted EBITDA for the applicable period divided by the revenue for that period presented in accordance with GAAP.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our shareholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons. Although we believe these measures are useful to investors and analysts for the same reasons they are useful to management, these measures are not a substitute for, or superior to, U.S. GAAP financial measures or disclosures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Reconciliation of historical Adjusted EBITDA and corresponding margin to their most directly comparable GAAP financial measures, net income/loss and corresponding margin are presented below. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items.


                                          
              
                Reconciliation of Adjusted EBITDA




                                                                                                        Three months ended                    Year ended
                                                                                                                                             
               December
                                                                                                                           December 31,                           31,



     
                
                  (in thousands, except percentages)                               2023         2022             2023         2022



     Net income                                                                                $10,164      $11,487           $7,238      $15,373



     Depreciation and amortization                                                              14,593       12,811           54,966       50,396



     Stock-based compensation                                                                   15,462       11,645           81,103       44,752



     Interest expense, net                                                                       2,489        3,194           12,236        9,053



     Provision (benefit) from income taxes                                                       3,858      (7,371)         (2,382)     (2,288)



     Restructuring and severance costs                                                           1,054        5,904            4,028       10,321



     Acquisition and integration costs                                                                         118                           97



     Foreign exchange (gain) loss, net                                                           (501)       1,246              430        4,798



     Employee retention tax credit                                                                                                     (6,981)



     Offering costs, impairments and other costs                                                   396        1,003            1,913        1,058



     Adjusted EBITDA                                                                           $47,515      $40,037         $159,532     $126,579



     Revenue                                                                                  $134,295     $117,435         $474,369     $408,348



     Net income margin                                                                             8 %        10 %             2 %         4 %



     Adjusted EBITDA margin                                                                       35 %        34 %            34 %        31 %


                                   
              
       Stock-Based Compensation




                                                                            Three months ended                  Year ended

                                                                                               December 31,                December 31,



     
                
                  (in thousands)                       2023         2022            2023       2022



     Cost of revenue                                                  $124         $249            $452       $507



     Sales and marketing                                             5,512        2,871          23,371     13,520



     Technology and development                                      4,104        2,958          17,538      9,937



     General and administrative                                      5,722        5,567          39,742     20,788



     
                Total stock-based compensation                   $15,462      $11,645         $81,103    $44,752

Conference Call and Webcast Information
IAS will host a conference call and live webcast to discuss its fourth quarter and full year 2023 financial results today at 5:00 p.m. ET. To access the live webcast and conference call dial-in, please register under the "News & Events" section of IAS's investor relations website. A replay will be available on IAS's investor relations website following the live call: https://investors.integralads.com.

About Integral Ad Science
Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry's most actionable data to drive superior results for the world's largest advertisers, publishers, and media platforms. IAS's software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust, safety, and transparency in digital media quality. For more information, visit integralads.com.

Forward-Looking Statements
This earnings press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate," "estimate," "expect," "project," "plan," "intend," "believe," "may," "will," "should," "can have," "likely," and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected costs, expenditures, cash flows, growth rates and financial results or our plans and objectives for future operations, growth initiatives or strategies are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: (i) the adverse effect on our business, operating results, financial condition, and prospects from various macroeconomic factors, including instability in geopolitical or market conditions; (ii) our failure to innovate or make the right investment decisions; (iii) our ability to provide digital or cross-platform analytics; (iv) our failure to maintain or achieve industry accreditation standards; (v) our dependence on integrations with advertising platforms, demand side providers ("DSPs") and proprietary platforms that we do not control; (vi) our ability to compete successfully with our current or future competitors in an intensely competitive market; (vii) our inability to use software licensed from third parties; (viii) our international expansion; (ix) our ability to expand into new channels; (x) our ability to sustain our profitability and revenue growth rate; (xi) risks that our customers do not pay or choose to dispute their invoices; (xii) risks of material changes to revenue share agreements with certain DSPs; (xiii) our dependence on the overall demand for advertising; (xiv) our ability to effectively manage our growth; (xv) the impact that any acquisitions we have completed in the past and may consummate in the future, strategic investments, or alliances may have on our business, financial condition, and results of operations; (xvi) our ability to successfully execute our international plans; (xvii) the risks associated with the seasonality of our market; (xviii) our ability to maintain high impression volumes; (xix) the difficulty in evaluating our future prospects given our short operating history; (xx) uncertainty in how the market for buying digital advertising verification solutions will evolve; (xxi) interruption by man-made problems such as terrorism, computer viruses, or social disruptions; (xxii) the risk of failures in the systems and infrastructure supporting our solutions and operations; (xxiii) our ability to avoid operational, technical, and performance issues with our platform; (xxiv) risks associated with any unauthorized access to user, customer, or inventory and third-party provider data; (xxv) our ability to provide the non-proprietary technology, software, products, and services that we use; (xxvi) the risk that we are sued by third parties for alleged infringement, misappropriation, or other violation of their proprietary rights; (xxvii) our ability to obtain, maintain, protect, or enforce intellectual property and proprietary rights that are important to our business; (xxviii) our involvement in lawsuits to protect or enforce our intellectual property; (xxix) risks that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers; (xxx) risks that our trademarks and trade names are not adequately protected; (xxxi) the impact of unforeseen changes to privacy and data protection laws and regulation on digital advertising; (xxxii) our ability to maintain our corporate culture; (xxxiii) public health outbreaks, epidemics, pandemics, or other public health crises; (xxxiv) risks posed by earthquakes, fires, floods, and other natural catastrophic events; (xxxv) the risk that a perceived failure to comply with laws and industry self-regulation may damage our reputation; and (xxxvi) other factors disclosed in our filings with the SEC. Given these factors, as well as other variables that may affect our operating results, you should not rely on forward-looking statements, assume that past financial performance will be a reliable indicator of future performance, or use historical trends to anticipate results or trends in future periods.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward- looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor Contact:
Jonathan Schaffer / Lauren Hartman
ir@integralads.com

Media Contact:
press@integralads.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-reports-fourth-quarter-and-full-year-2023-financial-results-302073075.html

SOURCE Integral Ad Science, Inc.